Literature DB >> 12242337

Structural characterization of the PIT-1/ETS-1 interaction: PIT-1 phosphorylation regulates PIT-1/ETS-1 binding.

Kevin D Augustijn1, Dawn L Duval, Rainer Wechselberger, Rob Kaptein, Arthur Gutierrez-Hartmann, Peter C van der Vliet.   

Abstract

The POU-domain transcription factor Pit-1 and Ets-1, a member of the ETS family of transcription factors, can associate in solution and synergistically activate the prolactin promoter by binding to a composite response element in the prolactin promoter. We mapped the minimal region of Ets-1 required for the interaction with the Pit-1 POU-homeodomain. Here, we describe a detailed NMR study of the interaction between the POU-homeodomain of Pit-1 and the minimal interacting region of Ets-1. By using heteronuclear single quantum coherence titration experiments, we were able to map exact residues on the POU-homeodomain that are involved in the interaction with this minimal Ets-1 interaction domain. By using our NMR data, we generated point mutants in the POU-homeodomain and tested their effect on the interaction with Ets-1. Our results show that phosphorylation of Pit-1 can regulate the interaction with Ets-1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12242337      PMCID: PMC130516          DOI: 10.1073/pnas.192693499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types.

Authors:  J S Dasen; S M O'Connell; S E Flynn; M Treier; A S Gleiberman; D P Szeto; F Hooshmand; A K Aggarwal; M G Rosenfeld
Journal:  Cell       Date:  1999-05-28       Impact factor: 41.582

2.  POU-domain proteins Pit-1 and Oct-1 interact to form a heteromeric complex and can cooperate to induce expression of the prolactin promoter.

Authors:  J W Voss; L Wilson; M G Rosenfeld
Journal:  Genes Dev       Date:  1991-07       Impact factor: 11.361

3.  Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions.

Authors:  I Radhakrishnan; G C Pérez-Alvarado; D Parker; H J Dyson; M R Montminy; P E Wright
Journal:  Cell       Date:  1997-12-12       Impact factor: 41.582

4.  Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility.

Authors:  E M Jacobson; P Li; A Leon-del-Rio; M G Rosenfeld; A K Aggarwal
Journal:  Genes Dev       Date:  1997-01-15       Impact factor: 11.361

5.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

6.  Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1).

Authors:  A I Castillo; A M Jimenez-Lara; R M Tolon; A Aranda
Journal:  Mol Endocrinol       Date:  1999-07

7.  A Pit-1 phosphorylation mutant can mediate both basal and induced prolactin and growth hormone promoter activity.

Authors:  D J Fischberg; X H Chen; C Bancroft
Journal:  Mol Endocrinol       Date:  1994-11

8.  Pit-1 binding sites mediate transcriptional responses to cyclic adenosine 3',5'-monophosphate through a mechanism that does not require inducible phosphorylation of Pit-1.

Authors:  Y Okimura; P W Howard; R A Maurer
Journal:  Mol Endocrinol       Date:  1994-11

9.  Signal-specific co-activator domain requirements for Pit-1 activation.

Authors:  L Xu; R M Lavinsky; J S Dasen; S E Flynn; E M McInerney; T M Mullen; T Heinzel; D Szeto; E Korzus; R Kurokawa; A K Aggarwal; D W Rose; C K Glass; M G Rosenfeld
Journal:  Nature       Date:  1998-09-17       Impact factor: 49.962

Review 10.  Genetic regulation of the embryology of the pituitary gland and somatotrophs.

Authors:  L E Cohen
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.925

View more
  8 in total

Review 1.  Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.

Authors:  Adwitiya Kar; Arthur Gutierrez-Hartmann
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-09-25       Impact factor: 8.250

2.  Phosphorylation of BRN2 modulates its interaction with the Pax3 promoter to control melanocyte migration and proliferation.

Authors:  Irina Berlin; Laurence Denat; Anne-Lise Steunou; Isabel Puig; Delphine Champeval; Sophie Colombo; Karen Roberts; Elise Bonvin; Yveline Bourgeois; Irwin Davidson; Véronique Delmas; Laurence Nieto; Colin R Goding; Lionel Larue
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

Review 3.  Genomic and biochemical insights into the specificity of ETS transcription factors.

Authors:  Peter C Hollenhorst; Lawrence P McIntosh; Barbara J Graves
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

4.  Ets family proteins regulate the EMT transcription factors Snail and ZEB in cancer cells.

Authors:  Mai Koizumi Ichikawa; Kaori Endo; Yuka Itoh; Asami Hotta Osada; Yujiro Kimura; Koichiro Ueki; Kunio Yoshizawa; Keiji Miyazawa; Masao Saitoh
Journal:  FEBS Open Bio       Date:  2022-04-29       Impact factor: 2.792

5.  A Pit-1 threonine 220 phosphomimic reduces binding to monomeric DNA sites to inhibit Ras and estrogen stimulation of the prolactin gene promoter.

Authors:  Annie Jean; Arthur Gutierrez-Hartmann; Dawn L Duval
Journal:  Mol Endocrinol       Date:  2009-11-03

Review 6.  The biology of the Ets1 proto-oncogene.

Authors:  Jürgen Dittmer
Journal:  Mol Cancer       Date:  2003-08-20       Impact factor: 27.401

7.  Biochemical and structural characterization of a novel cooperative binding mode by Pit-1 with CATT repeats in the macrophage migration inhibitory factor promoter.

Authors:  Sorabh Agarwal; Thomas Yoonsang Cho
Journal:  Nucleic Acids Res       Date:  2018-01-25       Impact factor: 16.971

8.  Discovery of novel determinants of endothelial lineage using chimeric heterokaryons.

Authors:  Wing Tak Wong; Gianfranco Matrone; XiaoYu Tian; Simion Alin Tomoiaga; Kin Fai Au; Shu Meng; Sayumi Yamazoe; Daniel Sieveking; Kaifu Chen; David M Burns; James K Chen; Helen M Blau; John P Cooke
Journal:  Elife       Date:  2017-03-21       Impact factor: 8.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.